Conference Reports for NATAP
EASL 45th Annual Meeting
April 14-18, 2010
Vienna, Austria
Back
 
Triple Combinations of Direct-Acting Antiviral Agents Demonstrate Robust Anti-HCV Activity In Vitro
Idenix Pharma
Reported by Jules Levin
EASL
Apr 14-18 2010 Vienna Austria